LONG TERM FOLLOW-UP OF A COHORT OF PATIENTS WITH THERAPY RELATED ACUTE LYMPHOBLASTIC LEUKEMIA: CLINICAL CHARACTERISTICS AND SURVIVAL.

EHA Library, Brayan Merchan, 294310

TUMOR BURDEN AND OUTCOME AFTER BLINATUMOMAB IN ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. RESULTS OF THE FRENCH-CYTO STUDY

EHA Library, Aurélie Cabannes-Hamy, 294311

A GENOME-WIDE APPROACH IDENTIFIES VARIATION IN THE UGT1A GENE LOCUS AS SIGNIFICANT CONTRIBUTOR TO CHEMOTHERAPY-RELATED HYPERBILIRUBINEMIA

EHA Library, Stefanie V. Junk, 294312

HIGH EFFICACY AND SAFETY OF RUXOLITINIB IN TREATING STEROIDS RESISTANT CRS DURING CAR T THERAPY, A PILOT STUDY

EHA Library, Jing Pan, 294313

TREATMENT OF ADULTS WITH RELAPSED/REFRACTORY PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA WITH BLINATUMOMAB IN A REAL-WORLD SETTING: RESULTS FROM THE NEUF STUDY

EHA Library, Sabina Chiaretti, 294314

INOTUZUMAB OZOGAMICIN WITH BOSUTINIB IN RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE (CML-LBP)

EHA Library, Nitin Jain, 294315

DETECTION OF MRD IN CLONAL IGH-V(D)J REARRANGEMENTS BY NEXT-GENERATION SEQUENCING MAY BETTER PREDICT RELAPSE RISK THAN MULTIPARAMETER FLOW CYTOMETRY IN ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Li-Xin Wu, 294316

CLONAL HETEROGENEITY AND RELATED CLINICAL STUDY IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, xiaodong lyu, 294317

AN OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY TO EVALUATE EFFICACY AND SAFETY OF BLINATUMOMAB IN CHINESE ADULTS WITH RELAPSED/REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jianxiang Wang, 294318

A HIGHER DOSE OF DASATINIB MAY INCREASE THE POSSIBILITY OF CROSSING THE BLOOD-BRAIN BARRIER IN THE TREATMENT OF PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jianxiang Wang, 294319

BLINATUMOMAB USE DURING CONSOLIDATION IN ADULT PATIENTS WITH HIGH-RISK, PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: PRELIMINARY RESULTS OF THE BLIN01 TRIAL.

EHA Library, Josep Maria Ribera, 294320

CAG REGIMEN FOR REFRACTORY OR RELAPSED ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A RETROSPECTIVE, MULTICENTER, COHORT STUDY

EHA Library, Honghu Zhu, 294321

MONITORING 24 CYTOKINES BY CYTOMETRIC BEAD ARRAY DURING THE CHIMERIC ANTIGEN RECEPTOR T CELLS TREATMENT

EHA Library, Dongchu Wang, 294322

LIVER SURVEILLANCE IN PATIENTS WHO RECEIVED INOTUZUMAB OZOGAMICIN (IO) FOR RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Giovanni Marconi, 294323

HIGH EFFICACY AND SAFETY OF CAR-T CELL THERAPY IN R/R B-ALL CHILDREN WITH HIGH LEUKEMIA BURDEN IN CENTRAL NERVOUS SYSTEM

EHA Library, Yue Tan, 294324

FINAL ANALYSIS OF THE GMALL-PH-01 TRIAL: PHASE II STUDY OF STANDARD CHEMOTHERAPY IN COMBINATION WITH DASATINIB IN FIRST LINE TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Fabian Lang, 294325

LONGITUDINAL THERAPEUTIC DRUG MONITORING TO OPTIMIZE PEGASPARGASE DOSING IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

EHA Library, Andre Schuh, 294326

THE DEVELOPMENT OF GLOBAL PEDIATRIC ONCOLOGY GUIDELINES: A FOCUS ON THE NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN®) PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA GUIDELINES

EHA Library, Hiroto Inaba, 294327

OUTCOMES OF ADOLESCENT AND YOUNG ADULTS(AYA) WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED ON A MODIFIED BFM-90 PROTOCOL- A SINGLE CENTRE EXPERIENCE

EHA Library, Akhil Rajendra, 294328

INOTUZUMAB OZAGAMICIN IS SAFE AND EFFECTIVE IN RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE ITALIAN CENTER EXPERIENCE

EHA Library, Chiara Sartor, 294329

INOTUZUMAB OZAGAMICIN AND DONOR LYMPHOCYTE INFUSION ARE A SAFE AND PROMISING COMBINATION IN RELAPSED ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER ALLOGENEIC TRANSPLANT

EHA Library, Chiara Sartor, 294330

TAS2R30 AND DAAM2 GENE DELETERIOUS MUTATION MAY CAUSE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN

EHA Library, Xuedong Wu, 294331

EVALUATION OF ALL SUSCEPTIBILITY LOCI IN PEDIATRIC B-CELL PRECURSOR ALL (BCP-ALL) PATIENTS IN RUSSIA

EHA Library, Grigory Tsaur, 294332

DOSE REDUCED CHEMOTHERAPY IN COMBINATION WITH BLINATUMOMAB FOR NEWLY DIAGNOSED OLDER PATIENTS WITH PH-NEGATIVE B-PRECURSOR ALL: FIRST RESULTS OF THE BOLD TRIAL

EHA Library, Nicola Gökbuget, 294333

EFFICACY AND SAFETY OF BLINATUMOMAB IN ASIAN ADULTS WITH RELAPSED/REFRACTORY B-PRECURSOR ALL

EHA Library, Yukio Kobayashi, 294334

EVALUATION OF THE DIAGNOSTIC ALGORITHM IN PH-LIKE ALL

EHA Library, Helena Podgornik, 294335

DETECTION OF MINIMAL RESIDUAL DISEASE IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIAUSING FLOW CYTOMETRY IN RUSSIAN MULTICENTER STUDY 'RALL-2016'

EHA Library, Olga Aleshina Gavrilina, 294336

THE TOLERABILITY AND EFFICACY OF ASPARAGINASE IN ADULTS AGE 40 YEARS AND OLDER WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Matthew James Rees, 294337

TKI MAINTENANCE AFTER CART THERAPY FOR THE TREATMENT OF RELAPSED PHILADELPHIA CHROMOSOME-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Lin Yuehui, 294338

EFFICACY OF BLINATUMOMAB IN THE SETTING OF COMBINED IMMUNODEFICIENCY SECONDARY TO SCHIMKE IMMUNO-OSSEOUS DYSPLASIA.

EHA Library, Dr Pemantah Sandheeah Ramdeny, 294339

IMMUNOPHENOTYPE OF MEASURABLE RESIDUAL BLAST CELLS OF ADULT PH-NEGATIVE B-ALL PATIENTS TREATED IN RUSSIAN STUDY RALL-2016

EHA Library, Yulia Davydova, 294341

PH NEGATIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN ADOLESCENTS AND YOUNG ADULTS (AYA): ARGENTINE REAL-WORLD DATA ON PROGNOSTIC FACTORS AND TREATMENT

EHA Library, Luciana Ferrari, 294342

INFECTION AND RISK FACTS IN ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA DURING INDUCTION TREATMENT

EHA Library, Kangyu Huang, 294343

AN ORAL, CHEMOTHERAPY-FREE REGIMEN (DASATINIB PLUS PREDNISONE) AS INDUCTION AND CONSOLIDATION FOR ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Hong-Hu Zhu, 294344

EFFICACY OF LOW DOSE RASBURICASE IN MANAGEMENT OF TUMOR LYSIS SYNDROME IN LEUKAEMIA AND LYMPHOMA PATIENTS

EHA Library, Gopila Gupta, 294345

VENETOCLAX PLUS DECITABINE IN THE TREATMENT OF MRD-PERSISTENT AND RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Elena Parovichnikova, 294346

PATTERNS OF MOLECULAR RESPONSE TO INDUCTION THERAPY IN ETV6-RUNX1+ ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Mariana Corrochano, 294347

OVER-EXPRESSION OF CRLF2 BY FLOW CYTOMETRY (FC) AND DEFINED BY RATIO B, IMPACTS ON DISEASE-FREE SURVIVAL (DFS) IN MEXICAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL).

EHA Library, Emmanuel Almanza Huante, 294348

COST-UTILITY OF PROTOCOLS OF BFM-ALL AND UK-ALL FOR TREATMENT OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN IRAN

EHA Library, Mohammadali Ehsani, 294349

ALLOGENEIC TRANSPLANTATION FOR ADULT PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH HIGH HYPERDIPLOIDY: A NATIONWIDE STUDY OF THE JAPAN SOCIETY FOR HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Shuhei Kurosawa, 294350

MANAGEMENT OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN A COUNTRY WITH LIMITED RESOURCES: A REAL LIFE MONOCENTRIC EXPERIENCE.

EHA Library, Mounir Ababou, 294351

FREQUENCY OF DISSEMINATED INTRAVASCULAR COAGULATION IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A RETROSPECTIVE ANALYSIS

EHA Library, Hayden Jina, 294352

TRANSFORMATION MECHANISMS OF THE NFIA-ETO2 FUSION ASSOCIATED WITH PEDIATRIC ACUTE ERYTHROLEUKEMIA

EHA Library, Maria Piqué-Borràs, 294354

A POTENT AND SELECTIVE SMALL MOLECULE DEGRADER OF STAT5 FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES

EHA Library, Patrick Gunning, 294355

THIORIDAZINE INDUCES CALCIUM OVERLOAD BEING TOXIC FOR KDM2A-AFDN REARRANGED ACUTE MYELOGENOUS LEUKEMIA

EHA Library, Elena Porcú, 294356

ONCOGENIC ROLE OF KEL IN LEUKEMOGENISIS AND PROGRESSION OF ACUTE ERYTHROLEUKEMIA

EHA Library, Hui Jin, 294357

THE CDK6-AS1 CONTROLS A NOVEL TRANSCRIPTIONAL CIRCUIT INVOLVED IN MYELOID DIFFERENTIATION AND CHEMOTHERAPY SENSITIVITY OF PEDIATRIC ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Maddalena Benetton, 294358

CONTINUOUS XPO1 INHIBITION WITH ELTANEXOR IS HIGHLY EFFECTIVE IN NPM1-MUTATED AML IN VIVO

EHA Library, Giulia Pianigiani, 294360

SIGNIFICANT EFFECT OF GEMTUZUMAB OZOGAMICIN ON MEASURABLE RESIDUAL DISEASE AND RISK OF RELAPSE IN PATIENTS WITH NEWLY DIAGNOSED NPM1 MUTATED AML- RESULTS FROM THE AMLSG 09-09 TRIAL

EHA Library, Silke Kapp-Schwoerer, 294361

NOVEL MOLECULAR PATHOGENESIS AND THERAPEUTIC TARGETS IN ACUTE ERYTHROID LEUKEMIA

EHA Library, June Takeda, 294362

REQUIREMENT FOR LIM KINASES IN ACUTE MYELOID LEUKEMIA

EHA Library, Patrizia Jensen, 294363

A DYNAMIC RIBOMETHYLOME DRIVES LEUKEMOGENESIS BY ACCELERATING AMINO ACID METABOLISM

EHA Library, Fengbiao Zhou, 294364

A NEW HYPOMETHYLATING AGENT, OR-2100, RESISTS DEGRADATION BY CYTIDINE DEAMINASE, LEADING TO FAVOURABLE ORAL ABSORBABILITY AND ANT-LEUKAEMIA EFFECTS

EHA Library, Hiroshi Ureshino, 294365

KNOCK-OUT OF HOPX DISRUPTS STEMNESS AND QUIESCENCE OF HEMATOPOIETIC STEM CELLS IN MICE

EHA Library, Chien-Chin Lin, 294366

IL-33/ST2 SIGNALING PROMOTES THE PROLIFERATION OF AML1/ETO LEUKEMIC STEM CELLS

EHA Library, Pascal Näf, 294367

CD44-INDUCED VLA-4 CLUSTERS AS COMMUNICATION HUBS OF LEUKEMIA CELLS WITH THE BONE MARROW ENVIRONMENT

EHA Library, Tanja Nicole Hartmann, 294368

DIFFERENTIATION THERAPY WITH NOVEL EPIGENETIC INHIBITORS IN ACUTE MYELOID LEUKEMIA

EHA Library, Edurne San Jose-Eneriz, 294369

ACUTE MYELOID LEUKEMIA SHAPES THE BONE MARROW STROMAL NICHE IN VIVO

EHA Library, Marta Biondi, 294370

EPIGENETIC AND IMMUNOMODULATORY EFFECTS OF AZACITIDINE (AZA) IN COMBINATION WITH THE ANTI-PD-L1 DURVALUMAB (DURVA) IN AML AND MDS: RESULTS FROM A LARGE, INTERNATIONAL, RANDOMIZED PHASE 2 STUDY

EHA Library, Isaac Boss, 294371

SELECTIVE DELIVERY OF ARA-C TO CXCR4+ CELLS, USING THE NANOCONJUGATE T22-GFP-H6-ARA-C, BLOCKS LEUKEMIA DISSEMINATION

EHA Library, Yáiza Núñez Amela, 294372

ACUTE MYELOID LEUKEMIA CELLS RESIST CHEMOTHERAPY THROUGH A TRANSIENT SENESCENCE-LIKE STATE

EHA Library, Cihangir Duy, 294373

PHARMACODYNAMIC (PD) RESPONSES TO CC-90009, A NOVEL CEREBLON E3 LIGASE MODULATOR (CELMOD), IN A PHASE 1 DOSE-ESCALATION STUDY IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (RR AML)

EHA Library, Daniel Pierce, 294374

NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE (MRD) MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION (FLT3-ITD+ AML) TREATED WITH ADDITIONAL MIDOSTAURIN

EHA Library, Julia K. Herzig, 294375

INTER-LABORATORY COMPARABILITY OF QUANTITATIVE ASSESSMENT OF MUTANT NPM1: RESULTS OF THE FIRST INTERNATIONAL ROUND-ROBIN TEST PERFORMED BY THE EUROPEAN LEUKEMIA NET (ELN) MRD WORKING PARTY (WP)

EHA Library, Christian Thiede, 294376

INDUCIBLE KNOCKDOWN IN PATIENT'S LEUKEMIA CELLS IN VIVO ALLOWS IDENTIFYING POTENT DRUG TARGETS IN INDIVIDUAL TUMORS IN A HIGHLY CLINIC-RELATED SETTING

EHA Library, Irmela Jeremias, 294377

PRL-PRLR AXIS AS A NEW POTENTIAL THERAPEUTIC TARGET AGAINST ACUTE MYELOID LEUKEMIA

EHA Library, Laia Cuesta-Casanovas, 294378

PHOSPHOPROTEOMIC PROFILING OF PRIMARY AML SAMPLES TO PREDICT EX VIVO RESPONSE TO FLT3-INHIBITORS.

EHA Library, David GJ Cucchi, 294379

ACTIVATED PENTOSE PHOSPHATE PATHWAY MEDIATED BY FBP1 UPREGULATION SUPPORTS PROGRESSION OF ACUTE MYELOID LEUKEMIA WITH HIGH EVI1 EXPRESSION

EHA Library, Hideaki Mizuno, 294380

SLIT2-KNOCKDOWN IS ASSOCIATED WITH DECREASED OVERALL SURVIVAL AND ARSENIC TRIOXIDE RESISTANCE IN APL CELLS.

EHA Library, Isabel Weinhäuser, 294382

VALIDATION THE OF PROGNOSTIC SIGNIFICANCE OF THE KNOWLEDGE BANK (KB) ALGORITHM IN ADULT ACUTE MYELOID LEUKEMIA (AML) PATIENTS (PTS) TREATED ON CALGB/ALLIANCE TRIALS AND SUGGESTIONS FOR IMPROVEMENTS

EHA Library, Marius Bill, 294383

AB8939, A NOVEL MICROTUBULE-DESTABILIZING AGENT FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA

EHA Library, Olivier Hermine, 294384

SCREENING OF NOVEL HYPOMETHYLATING COMPOUNDS FOR TREATMENT OF MDS/AML USING A SFRP1-DERIVED RECOMBINANT REPORTER SYSTEM

EHA Library, Angelique Ziegfeld, 294385

THE MODE OF ACTION (MOA) OF THE ANTI-CD38 MONOCLONAL ANTIBODY (MAB) ISATUXIMAB IN ELDERLY ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Aintzane Zabaleta, 294386

CLONAL EVOLUTION IN MURINE LEUKEMIA MODELS

EHA Library, Rhea Desai, 294387

MOLECULAR LANDSCAPE OF ACUTE MYELOID LEUKEMIA IN ADOLESCENTS AND YOUNG ADULTS

EHA Library, Laurène Fenwarth, 294388

DASATINIB RESPONSE IN AML IS CORRELATED WITH FLT3/ITD, PTPN11 MUTATIONS AND A UNIQUE GENE EXPRESSION SIGNATURE.

EHA Library, Nathali Kaushanski, 294389

VALPROIC ACID DISABLES THE NRF2 ANTI-OXIDANT RESPONSE AND ENHANCES REACTIVE OXYGEN SPECIES-MEDIATED KILLING OF ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Yao Jiang, 294390

SIGNALING PATHWAY ACTIVITY ANALYSIS FOR PREDICTION OF DRUG RESISTANCE AND SENSITIVITY IN PEDIATRIC LEUKEMIAS.

EHA Library, Timofey Lebedev, 294391

THERAPEUTIC TARGETING OF DNA-PKCS WITH M3814 IN COMBINATION WITH CPX-351 (VYXEOS) ACHIEVES PROFOUND LEUKEMIA REDUCTION IN TP53WT AND TP53MUT ACUTE MYELOID LEUKEMIA

EHA Library, Yuki Nishida, 294392

OPTIMIZED CART CELLS TARGETING CD33 FOR TREATMENT OF R/R AML.

EHA Library, Cristina Calvino, 294394

CLINICAL RELEVANCE OF HOST IMMUNE GENETIC VARIATIONS ON THE RISK OF DEVELOPING ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE NUCLEAR CONSORTIUM

EHA Library, Juan Sainz, 294395

HIGHLY SENSITIVE MULTIDIMENSIONAL FLOW CYTOMETRY STRATEGY BASED ON INTEGRATED DFN/LAIP APPROACH FOR MINIMAL/ MEASURABLE RESIDUAL DISEASE DIAGNOSIS AND MONITORING IN ACUTE MYELOID LEUKEMIA

EHA Library, Paula Piñero, 294396

MUTANT P53 INCREASES STEM-CELL FREQUENCY BUT IS ASSOCIATED WITH REDUCED BINDING TO CLASSICAL TP53 BINDING SITES IN PRIMARY AML AND CELL LINES

EHA Library, Mylene Gerritsen, 294397

MLL5-MEDIATED EPIGENETIC REPROGRAMMING PROMOTES HIGHER MYELOID DIFFERENTIATION IN RESPONSE TO RA-BASED TREATMENT IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Diego A Pereira-Martins, 294398

INHIBITION OF AKT DOWNSTREAM SIGNALLING ENHANCES CHEMOTHERAPY RESPONSE IN KIT MUTANT AML

EHA Library, Montserrat Estruch Alrich, 294399

LOSS OF MIR-155-5P INCREASED THE TREATMENT SENSITIVITY TO CHEMOTHERAPY AND FLT3 INHIBITORS IN FLT3-ITD+AML VIA GLYCOLYSIS BLOCKING BY TARGETING PIK3R1

EHA Library, Lingyan Wang, 294400

DNA METHYLATION PROFILING ENABLES PROGNOSTIC CLASSIFICATION OF INTENSIVELY TREATED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Sebastian Vosberg, 294401

MUTATIONAL PROFILE OF T(11;17)(Q23;Q21)/ZBTB16-RARA –POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Emiliano Fabiani, 294402

IDH2 P.R172K MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) MAY BE ASSOCIATED WITH FAVORABLE RESPONSE TO SELINEXOR TREATMENT

EHA Library, Christopher Walker, 294403

CHARACTERIZATION AND TRANSFER OF EXTRACELLULAR VESICLES WITHIN THE BONE MARROW NICHE IN ACUTE MYELOID LEUKEMIA

EHA Library, Judith S. Hecker, 294404

A MULTI-OMICS APPROACH TO UNRAVEL GPR56-MODULATED PATHWAYS IN ACUTE MYELOID LEUKEMIA

EHA Library, Lixiazi He, 294405

COMBINED TARGETING DNA DAMAGE RESPONSE AND ANTI-APOPTOTIC PROGRAMS IN AML

EHA Library, Viral Shah, 294406

POTENTIAL THERAPEUTIC IMPLICATION OF CIP2A-MEDIATED PP2A MODULATION IN MIXED LINEAGE LEUKEMIA

EHA Library, Antonella Di Mambro, 294407

ROLE OF CD276 IN REMODELLING OF THE BONE MARROW MICROENVIRONMENT DURING LEUKAEMIA PROGRESSION

EHA Library, Antoniana Batsivari, 294408

DYSREGULATED EXPRESSION OF MICRORNAS CONTRIBUTES TO INFLAMMATORY AND NEOPLASTIC CHARACTERISTICS OF ERDHEIM-CHESTER DISEASE

EHA Library, Ran Weissman, 294409

TP53 MUTATED AML IS ASSOCIATED WITH AN IMMUNE DYSFUNCTION

EHA Library, Ghayas Issa, 294410

NON-GENOTOXIC COMBINATION TREATMENTS FOR PAEDIATRIC ACUTE MYELOID LEUKAEMIA

EHA Library, Mojgan Reza, 294411

A NOVEL MECHANISM OF VENETOCLAX RESISTANCE IN ACUTE MYELOID LEUKEMIA: DELETION OF BAX

EHA Library, Farid Ahmed, 294412

DRUG REPOSITIONING OF CABOZANTINIB TO TREATMENT OF LEUKEMIC CELLS WITH RUNX1-RUNX1T1 AND KIT MUTATION

EHA Library, Kuan-Wei Su, 294413

ADDITION OF THE PARP INHIBITOR, TALAZOPARIB TO GEMTUZUMAB OZOGAMICIN SIGNIFICANTLY ENHANCES ANTI-LEUKEMIC ACTIVITY IN HUMAN CD33+ ACUTE MYELOID LEUKEMIA

EHA Library, Marianna Giorgi, 294414